(0.71%) 5 054.19 points
(0.70%) 38 167 points
(1.20%) 15 793 points
(-0.10%) $78.92
(5.28%) $2.03
(0.10%) $2 313.40
(0.59%) $26.91
(1.09%) $965.30
(-0.04%) $0.933
(-0.31%) $11.00
(-0.02%) $0.798
(-1.41%) $91.95
Live Chart Being Loaded With Signals
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system...
Stats | |
---|---|
Šios dienos apimtis | 29 500.00 |
Vidutinė apimtis | 94 701.00 |
Rinkos kapitalizacija | 26.11B |
EPS | ¥19.18 ( 2024-02-13 ) |
Kita pelno data | ( ¥0 ) 2024-05-08 |
Last Dividend | ¥4.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 24.63 |
ATR14 | ¥1.412 (0.14%) |
Tūris Koreliacija
FINDEX Inc. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
FINDEX Inc. Koreliacija - Valiuta/Žaliavos
FINDEX Inc. Finansinės ataskaitos
Annual | 2023 |
Pajamos: | ¥5.19B |
Bruto pelnas: | ¥3.33B (64.13 %) |
EPS: | ¥41.31 |
FY | 2023 |
Pajamos: | ¥5.19B |
Bruto pelnas: | ¥3.33B (64.13 %) |
EPS: | ¥41.31 |
FY | 2022 |
Pajamos: | ¥4.54B |
Bruto pelnas: | ¥2.72B (59.96 %) |
EPS: | ¥28.21 |
FY | 2021 |
Pajamos: | ¥4.97B |
Bruto pelnas: | ¥2.56B (51.45 %) |
EPS: | ¥20.24 |
Financial Reports:
No articles found.
FINDEX Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥6.50 (N/A) |
¥0 (N/A) |
¥4.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥0.250 | 2011-12-28 |
Last Dividend | ¥4.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 23 | -- |
Total Paid Out | ¥74.42 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.56 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.25 | |
Div. Directional Score | 7.75 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8168.T | Ex Dividend Junior | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
7545.T | Ex Dividend Knight | 2024-02-19 | Semi-Annually | 0 | 0.00% | |
6755.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6098.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4801.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4023.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3232.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
2264.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9090.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7976.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.204 | 1.500 | 5.92 | 8.88 | [0 - 0.5] |
returnOnAssetsTTM | 0.178 | 1.200 | 4.05 | 4.86 | [0 - 0.3] |
returnOnEquityTTM | 0.243 | 1.500 | 8.41 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 6.48 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 5.97 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.32 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0558 | -1.500 | 9.07 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 2 394.51 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 6.53 | [0 - 30] |
freeCashFlowPerShareTTM | 20.20 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0685 | -1.500 | 9.73 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.641 | 1.000 | 2.64 | 2.64 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.288 | 1.000 | 6.23 | 6.23 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.564 | 1.000 | 2.42 | 2.42 | [0.2 - 2] |
assetTurnoverTTM | 0.875 | 0.800 | 7.50 | 6.00 | [0.5 - 2] |
Total Score | 11.26 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.67 | 1.000 | 7.61 | 0 | [1 - 100] |
returnOnEquityTTM | 0.243 | 2.50 | 8.98 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.276 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 6.53 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.819 | 1.500 | 1.208 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0998 | 1.000 | -0.00558 | 0 | [0.1 - 0.5] |
Total Score | 4.25 |
FINDEX Inc.
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.